Clinical Trial Update: Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Patients

View source ↗

Summary

A completed clinical trial from AstraZeneca evaluating how changes in inflammation relate to lung function, symptoms, and medication use in patients with COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED